Image from Google Jackets

Antipsychotic long-acting injections

Contributor(s):

Publication details: Oxford : Oxford University Press, 2016.Edition: 2nd edDescription: xxi, 366 pISBN:

9780198729471 (pbk.) :
0198729472 (pbk.) :

Subject(s):

NLM classification:

WM 402.

Summary: Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon. The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research. Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.

Holdings
Item type	Home library	Class number	Status	Date due	Barcode
Book	South London and Maudsley Trust Library Shelves	WM 402 ANT (Browse shelf(Opens below))	Available		022520

Browsing South London and Maudsley Trust Library shelves, Shelving location: Shelves Close shelf browser (Hides shelf browser)

Previous								Next
Previous	WM 401 KIN Tackling mental health crises	WM 401 PSY Psychiatric intensive care	WM 401 PUR Emergencies in psychiatry	WM 402 ANT Antipsychotic long-acting injections	WM 402 BEC Oxford handbook of nurse prescribing /	WM 402 BOY Medicine management skills for nurses /	WM 402 BRE Psychiatric drug withdrawal : a guide for prescribers, therapists, patients, and their families	Next

Antipsychotic Long-acting Injections (LAIs) were introduced in the 1960s to improve treatment adherence in schizophrenia. Subsequently, first-generation antipsychotic LAIs became widely used in many countries. Since the initial publication of Antipsychotic Long-acting Injections in 2010, new trial data have been published on long-acting injection (LAI) preparations of the drugs Risperidone, Paliperidone, and Olanzapine. Furthermore, a new LAI preparation of the drug Aripiprazole has recently been approved for clinical use in the United States and is likely to be approved in Europe soon.

The second edition of this successful book has been fully updated to include this new data, with reference to both observational studies and randomized controlled trials, as well as other new developments in the clinical use of antipsychotic LAIs. New chapters have been added covering the comparison between oral and injectable antipsychotics, Olanzapine LAI, Aripiprazole LAI, and the practicalities of organizing a specialized clinic for long-acting injectable antipsychotics. Existing chapters have also been thoroughly updated to take into account the most recently published research.

Antipsychotic Long-acting Injections, Second edition brings together clinical and research findings on LAIs in a comprehensive volume, with chapters written by international experts.

There are no comments on this title.

to post a comment.